Literature DB >> 8267446

Use of retrograde cold crystalloid cardioplegia in a patient with unexpected cold agglutination.

M B Izzat1, P B Rajesh, G H Smith.   

Abstract

Undetected cold agglutinins were encountered in a patient undergoing coronary artery bypass grafting using antegrade cold blood cardioplegia. Macroemboli were infused into the coronary arterial tree. These were flushed out by the use of retrograde cold crystalloid cardioplegia. Activated cold agglutinins may be hazardous in cold blood cardioplegia.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8267446     DOI： 10.1016/0003-4975(93)90692-b

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  5 in total

1.  Cold Agglutinin Autoantibodies in a Patient without a Visible Coronary Sinus Ostium: Strategies for Myocardial Protection without Using Retrograde Cardioplegia.

Authors:  Michele Heath; Suraj Yalamuri; Julie Walker; Cory Maxwell; Adam Williams; Sharon McCartney; Mani Daneshmand
Journal:  J Extra Corpor Technol       Date:  2016-06

2.  Bentall Surgery in a Patient with Cold Agglutinin and Antiphospholipid Antibody: Double Trouble.

Authors:  Monish S Raut; Gulshan Rohra; Ganesh Shivnani; Arun Maheshwari; Sumir Dubey; Rajpal Singh Bhathiwal; Deevakar Sharma
Journal:  J Extra Corpor Technol       Date:  2016-06

3.  [Acute ventricular septal perforation in a patient with autoimmune hemolytic anemia].

Authors:  H Matsumoto; T Yuda; T Ueno; A Taira
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-05

4.  Agglutinins and cardiac surgery: a web based survey of cardiac anaesthetic practice; questions raised and possible solutions.

Authors:  S Shah; H Gilliland; G Benson
Journal:  Heart Lung Vessel       Date:  2014

5.  Incidentally discovered cold hemagglutinin disease with massive blood clots in the cardioplegia line and coronary artery, during coronary artery bypass graft.

Authors:  Euysuk Chung; Sungjoon Park; Jaehoon Lee
Journal:  J Cardiothorac Surg       Date:  2020-05-11       Impact factor: 1.637
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.